148 related articles for article (PubMed ID: 15849886)
21. Predictive assay of neoadjuvant chemotherapy in management of oral cancer.
Tsuji T; Noguchi M; Kido Y; Kubota H; Takemura K; Nakamori K; Hiratsuka H
Int J Oral Maxillofac Surg; 2007 Jan; 36(1):15-9. PubMed ID: 17157477
[TBL] [Abstract][Full Text] [Related]
22. [Change in the prognosis of surgically treated cancer of the mouth mucosa in the course of time].
Tischendorf L
Fortschr Kiefer Gesichtschir; 1992; 37():48-50. PubMed ID: 1639311
[No Abstract] [Full Text] [Related]
23. Neoadjuvant and adjuvant therapy in patients with oral squamous cell carcinoma Long-term survival in a prospective, non-randomized study.
Kessler P; Grabenbauer G; Leher A; Bloch-Birkholz A; Vairaktaris E; Neukam FW
Br J Oral Maxillofac Surg; 2008 Jan; 46(1):1-5. PubMed ID: 17931758
[TBL] [Abstract][Full Text] [Related]
24. [Retrospective analysis of a mandible sparing therapy concept in cancers of the mouth floor].
Esser E; Krech RH
Fortschr Kiefer Gesichtschir; 1992; 37():95-8. PubMed ID: 1639330
[No Abstract] [Full Text] [Related]
25. Efficacy of induction selection chemotherapy vs primary surgery for patients with advanced oral cavity carcinoma.
Chinn SB; Spector ME; Bellile EL; Rozek LS; Lin T; Teknos TN; Prince ME; Bradford CR; Urba SG; Carey TE; Eisbruch A; Wolf GT; Worden FP; Chepeha DB
JAMA Otolaryngol Head Neck Surg; 2014 Feb; 140(2):134-42. PubMed ID: 24370563
[TBL] [Abstract][Full Text] [Related]
26. Treatment results and prognostic factors for advanced squamous cell carcinoma of the head and neck treated with concurrent chemoradiotherapy.
Taguchi T; Tsukuda M; Mikami Y; Matsuda H; Tanigaki Y; Horiuchi C; Nishimura G; Nagao J
Auris Nasus Larynx; 2009 Apr; 36(2):199-204. PubMed ID: 18632233
[TBL] [Abstract][Full Text] [Related]
27. What is the adequate margin of surgical resection in oral cancer?
Nason RW; Binahmed A; Pathak KA; Abdoh AA; Sándor GK
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 May; 107(5):625-9. PubMed ID: 19168372
[TBL] [Abstract][Full Text] [Related]
28. The value of squamous cell carcinoma antigen in the prognostic evaluation, treatment monitoring and followup of patients with penile cancer.
Zhu Y; Ye DW; Yao XD; Zhang SL; Dai B; Zhang HL; Shen YJ
J Urol; 2008 Nov; 180(5):2019-23. PubMed ID: 18801542
[TBL] [Abstract][Full Text] [Related]
29. Treatment of base of tongue cancer with paclitaxel, ifosfamide, and cisplatinum induction chemotherapy followed by chemoradiotherapy.
Hancock SB; Krempl GA; Canfield V; Bogardus C; Kojouri K; Kaneaster SK; Medina JE
Laryngoscope; 2008 Aug; 118(8):1357-61. PubMed ID: 18528311
[TBL] [Abstract][Full Text] [Related]
30. Prospective trial of ifosfamide, paclitaxel, and cisplatin in patients with advanced non-transitional cell carcinoma of the urothelial tract.
Galsky MD; Iasonos A; Mironov S; Scattergood J; Donat SM; Bochner BH; Herr HW; Russo P; Boyle MG; Bajorin DF
Urology; 2007 Feb; 69(2):255-9. PubMed ID: 17320659
[TBL] [Abstract][Full Text] [Related]
31. Postoperative follow-up strategy in patients with oral squamous cell carcinoma.
Sasaki M; Aoki T; Karakida K; Otsuru M; Takahashi M; Akamatsu T; Sakamoto H; Ota Y
J Oral Maxillofac Surg; 2011 Jun; 69(6):e105-11. PubMed ID: 21419541
[TBL] [Abstract][Full Text] [Related]
32. Prognostic factors and the treatment of the negative neck in oral carcinoma.
Panizza B
ANZ J Surg; 2009; 79(1-2):7-8. PubMed ID: 19183369
[No Abstract] [Full Text] [Related]
33. [Clinical effects of concurrent chemoradiotherapy (hyperfractionation and cisplatin/5-fluorouracil) for patients with advanced oral squamous cell carcinoma].
Tsuchiya Y; Noguchi T; Matsumoto K; Matsumura T; Hoshi K; Ito H; Osano H; Jinbu Y; Kusama M
Gan To Kagaku Ryoho; 2009 Jan; 36(1):101-3. PubMed ID: 19151572
[TBL] [Abstract][Full Text] [Related]
34. [Epidermoid carcinomas of anal canal treated with radiation therapy and concomitant chemotherapy (5-fluorouracil and cisplatin)].
Deniaud-Alexandre E; Touboul E; Tiret E; Sezeur A; Hannoun L; Houry S; Huguet F; Pène F; Parc R; Schlienger M
Cancer Radiother; 2006 Dec; 10(8):572-82. PubMed ID: 17110148
[TBL] [Abstract][Full Text] [Related]
35. Neoadjuvant radiochemotherapy and radical resection for advanced squamous cell carcinoma of the oral cavity. Outcome of 134 patients.
Eich HT; Löschcke M; Scheer M; Kocher M; Bongartz R; Wacker S; Zöller JE; Müller RP
Strahlenther Onkol; 2008 Jan; 184(1):23-9. PubMed ID: 18188519
[TBL] [Abstract][Full Text] [Related]
36. [Preoperative chemotherapy with S-1 and low-dose cisplatin for oral squamous cell carcinoma].
Nakazawa M
Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():184-8. PubMed ID: 16897999
[TBL] [Abstract][Full Text] [Related]
37. [Onco-surgical radical treatment, recurrence and rehabilitation in the Jena Clinic patient sample (1968-1989)].
Schumann D; Hyckel P; Müller P; Mansel B
Fortschr Kiefer Gesichtschir; 1992; 37():37-9. PubMed ID: 1639307
[No Abstract] [Full Text] [Related]
38. Loss of 14-3-3 sigma protein expression and presence of human papillomavirus type 16 E6 in oral squamous cell carcinoma.
Bhawal UK; Sugiyama M; Nomura Y; Kuniyasu H; Tsukinoki K
Arch Otolaryngol Head Neck Surg; 2008 Oct; 134(10):1055-9. PubMed ID: 18936350
[TBL] [Abstract][Full Text] [Related]
39. [Maxillary cancers--a retrospective study].
Zahn W; Machtens E; Radtke J
Fortschr Kiefer Gesichtschir; 1992; 37():124-7. PubMed ID: 1639297
[No Abstract] [Full Text] [Related]
40. Necrosis of the tongue after arterial chemotherapy.
Shih CT; Hao SP; Ng SH; Yen KC
Otolaryngol Head Neck Surg; 1999 Nov; 121(5):655-7. PubMed ID: 10547491
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
